申请人:BEIJING HANMI PHARMACEUTICAL CO., LTD.
公开号:US20170368028A1
公开(公告)日:2017-12-28
Disclosed are a compound, a stereisomer and a tautomer thereof, a pharmaceutically acceptable salt thereof, and a solvate or a prodrug thereof, which can be used for preventing or treating a RORγ mediated disease. The compound has the structural formula (I).